AUPH Aurinia Pharmaceuticals Inc gains 48% Nov 9, 2021

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.http://www.priceseries.com/trade/AUPH-Aurinia-Pharmaceuticals-Inc-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2021102020211109.html